Pricing Log in Create free account

Creative Medical Technology Holdings, Inc. (CELZ) vs Orgenesis Inc. (ORGS)

Creative Medical Technology Holdings, Inc. and Orgenesis Inc. are both Biotechnology companies. Creative Medical Technology Holdings, Inc. and Orgenesis Inc. are of similar size ($5.7M and $5.4M). Orgenesis Inc. grew revenue faster over the last twelve months: 95.3% against −79.4%. Creative Medical Technology Holdings, Inc. has the higher net margin (0.00% vs −4,653.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Creative Medical Technology Holdings, Inc. leads on 9 and Orgenesis Inc. on 7.

Valuation

Metric CELZ ORGS Biotechnology median
P/E n/m n/m 8.50
P/S 161.13 0.24 9.71
P/B 0.32 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.98 n/m 0.64
EV/Sales (351.86) 15.71 9.21
Earnings yield (279.73%) (19,183.33%) (33.15%)
Free cash flow yield (409.71%) (6,862.91%) (25.50%)

Profitability

Metric CELZ ORGS Biotechnology median
Gross margin 61.18% (86.28%) 65.16%
Operating margin 0.00% (3,842.32%) 0.00%
Net margin 0.00% (4,653.62%) 0.00%
Free cash flow margin 0.00% (1,675.27%) 0.00%
Return on equity (77.91%) 164.62% (56.36%)
Return on assets (73.30%) (605.73%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CELZ ORGS Biotechnology median
Revenue growth (TTM) (79.42%) 95.28% 6.02%
EPS growth (last fiscal year) 32.08% 40.10% 30.26%
Revenue growth, 5-year CAGR (48.43%) (23.30%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELZ ORGS Biotechnology median
Debt to equity 0.00 (0.44) 0.00
Current ratio 12.91 0.03 4.72
Net debt to EBITDA 1.20 (0.42) 0.96

Dividend

Metric CELZ ORGS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CELZ ORGS Biotechnology median
Market cap 5.39m 5.68m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack